首页> 美国卫生研究院文献>other >Comparison of Microdialysis Sampling Perfusion Fluid Components on the Foreign Body Reaction in Rat Subcutaneous Tissue
【2h】

Comparison of Microdialysis Sampling Perfusion Fluid Components on the Foreign Body Reaction in Rat Subcutaneous Tissue

机译:微透析采样灌注液成分对大鼠皮下组织异物反应的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microdialysis sampling is a commonly used technique for collecting solutes from the extracellular space of tissues in laboratory animals and humans. Large molecular weight solutes can be collected using high molecular weight cutoff (MWCO) membranes (100 kDa or greater). High MWCO membranes require addition of high molecular weight dextrans or albumin to the perfusion fluid to prevent fluid loss via ultrafiltration. While these perfusion fluid additives are commonly used during microdialysis sampling, the tissue response to the loss of these compounds across the membrane is poorly understood. Tissue reactions to implanted microdialysis sampling probes containing different microdialysis perfusion fluids were compared over a 7-day time period in rats. The base perfusion fluid was Ringer’s solution supplemented with either bovine serum albumin (BSA), rat serum albumin (RSA), Dextran-70, or Dextran-500. A significant inflammatory response to Dextran-70 was observed. No differences in the tissue response between BSA and RSA were observed. Among these agents, the BSA, RSA, and Dextran-500 produced a significantly reduced inflammatory response compared to the Dextran-70. This work demonstrates that use of Dextran-70 in microdialysis sampling perfusion fluids should be eliminated and replaced with Dextran-500 or other alternatives.
机译:微透析采样是从实验动物和人类组织的细胞外空间收集溶质的常用技术。可以使用高分子量截留(MWCO)膜(100 kDa或更大)收集大分子量溶质。高MWCO膜需要向灌注液中添加高分子量的葡聚糖或白蛋白,以防止液体通过超滤损失。尽管这些灌注液添加剂通常在微透析采样期间使用,但对这些化合物在整个膜上损失的组织响应知之甚少。在大鼠的7天时间段内,比较了对植入的包含不同微透析灌注液的微透析采样探针的组织​​反应。基本灌注液是林格氏溶液,其中补充了牛血清白蛋白(BSA),大鼠血清白蛋白(RSA),Dextran-70或Dextran-500。观察到对Dextran-70有明显的炎症反应。没有观察到BSA和RSA之间的组织反应有差异。在这些试剂中,与Dextran-70相比,BSA,RSA和Dextran-500产生的炎症反应明显减少。这项工作表明,应避免在微透析采样灌注液中使用Dextran-70,并用Dextran-500或其他替代方法代替。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号